ENDOTHELIAL AND VASCULAR SMOOTH-MUSCLE FUNCTION IN SEPSIS

被引:41
作者
HOLLENBERG, SM [1 ]
CUNNION, RE [1 ]
机构
[1] RUSH PRESBYTERIAN ST LUKES MED CTR,DIV CARDIOL,CHICAGO,IL 60612
关键词
D O I
10.1016/0883-9441(94)90006-X
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
The vascular abnormalities that arise during sepsis imply disturbances in the delicately tuned homeostatic mechanisms of vascular endothelium and smooth muscle. In the microvasculature, smooth muscle tone represents a complex equilibrium among metabolic stimuli, hemodynamic forces, and neurohumoral influences. Local tissue perfusion also is modulated by vasoactive mediators that can be produced locally, through endothelium-dependent adhesion and activation of inflammatory cells, or at a distance. In sepsis, derangement of normal autoregulation of perfusion, together with toxic effects of mediators, may be severe enough to result in organ dysfunction. Recent advances in vascular biology have illuminated a variety of targets, such as adhesion molecules, platelet activating factor, and inducible nitric oxide synthase for potential therapeutic intervention in sepsis. Copyright (C) 1994 by W.B. Saunders Company
引用
收藏
页码:262 / 280
页数:19
相关论文
共 123 条
  • [71] McKenna, Prolonged exposure of rat aorta to low levels of endotoxin in vitro results in impaired contractility. Association with vascular cytokine release, J Clin Invest, 86, pp. 160-168, (1990)
  • [72] McKenna, Martin, Chernow, Et al., Vascular endothelium contributes to decreased aortic contractility in experimental sepsis, Circ Shock, 19, pp. 267-273, (1986)
  • [73] Meininger, Davis, Cellular mechanisms involved in the vascular myogenic response, Am J Physiol, 263, pp. H647-H659, (1992)
  • [74] Meyer, Traber, Nelson, Et al., Reversal of hyperdynamic response to continuous endotoxin administration by inhibition of NO synthesis, J Appl Physiol, 73, pp. 324-328, (1992)
  • [75] Moncada, Gryglewski, Bunting, Et al., An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation, Nature, 263, pp. 663-665, (1976)
  • [76] Moncada, Palmer, Higgs, Nitric oxide: physiology, pathophysiology, and pharmacology, Pharmacol Rev, 43, pp. 109-142, (1991)
  • [77] Moore, Andreoli, Esmon, Et al., Endotoxin enhances tissue factor and suppresses thrombomodulin expression of human vascular endothelium in vitro, J Clin Invest, 79, pp. 124-130, (1987)
  • [78] Myers, Minor, Guerra, Et al., Vasorelaxant properties of the endothelium-derived relaxing factor more closely resemble S-nitrocysteine than nitric oxide, Nature, 345, pp. 161-163, (1990)
  • [79] Natanson, Eichenholz, Danner, Et al., Endotoxin and tumor necrosis factor challenges in dogs simulate the cardiovascular profile of human septic shock, J Exp Med, 169, pp. 823-832, (1989)
  • [80] Natanson, Hoffman, Suffredini, Et al., Selected treatment strategies for septic shock based on proposed mechanisms of pathogenesis, Ann Intern Med, 120, pp. 771-783, (1994)